U.S. flag An official website of the United States government
  1. Home
  2. Drug Databases
  3. Drugs@FDA

Drugs@FDA: FDA-Approved Drugs

Home | Previous Page

Abbreviated New Drug Application (ANDA): 204644
Company: MYLAN
Drug Name Active Ingredients Strength Dosage Form/Route Marketing Status TE Code RLD RS
IMATINIB MESYLATE IMATINIB MESYLATE EQ 100MG BASE TABLET;ORAL Prescription AB No No
IMATINIB MESYLATE IMATINIB MESYLATE EQ 400MG BASE TABLET;ORAL Prescription AB No No
Original Approvals or Tentative Approvals
Action Date Submission Action Type Submission Classification Review Priority; Orphan Status Letters, Reviews, Labels, Patient Package Insert Notes Url
06/21/2017 ORIG-1 Approval

Label is not available on this site.

Supplements
Action Date Submission Supplement Categories or Approval Type Letters, Reviews, Labels, Patient Package Insert Note Url
01/05/2024 SUPPL-15 Labeling-Package Insert, Labeling-Container/Carton Labels

Label is not available on this site.

01/05/2024 SUPPL-11 Labeling-Package Insert

Label is not available on this site.

01/05/2024 SUPPL-8 Labeling-Package Insert

Label is not available on this site.

01/05/2024 SUPPL-5 Labeling-Package Insert

Label is not available on this site.

01/05/2024 SUPPL-3 Labeling-Package Insert

Label is not available on this site.

01/05/2024 SUPPL-2 Labeling-Package Insert

Label is not available on this site.

IMATINIB MESYLATE

TABLET;ORAL; EQ 100MG BASE
TE Code = AB

Drug Name Active Ingredients Strength Dosage Form/Route Marketing Status RLD TE Code Application No. Company
GLEEVEC IMATINIB MESYLATE EQ 100MG BASE TABLET;ORAL Prescription Yes AB 021588 NOVARTIS
IMATINIB MESYLATE IMATINIB MESYLATE EQ 100MG BASE TABLET;ORAL Prescription No AB 079179 APOTEX
IMATINIB MESYLATE IMATINIB MESYLATE EQ 100MG BASE TABLET;ORAL Prescription No AB 208429 CHARTWELL RX
IMATINIB MESYLATE IMATINIB MESYLATE EQ 100MG BASE TABLET;ORAL Prescription No AB 206547 DR REDDYS
IMATINIB MESYLATE IMATINIB MESYLATE EQ 100MG BASE TABLET;ORAL Prescription No AB 212773 EUGIA PHARMA
IMATINIB MESYLATE IMATINIB MESYLATE EQ 100MG BASE TABLET;ORAL Prescription No AB 204644 MYLAN
IMATINIB MESYLATE IMATINIB MESYLATE EQ 100MG BASE TABLET;ORAL Prescription No AB 207818 NATCO PHARMA LTD
IMATINIB MESYLATE IMATINIB MESYLATE EQ 100MG BASE TABLET;ORAL Prescription No AB 212135 QILU PHARM HAINAN
IMATINIB MESYLATE IMATINIB MESYLATE EQ 100MG BASE TABLET;ORAL Prescription No AB 208302 SHILPA
IMATINIB MESYLATE IMATINIB MESYLATE EQ 100MG BASE TABLET;ORAL Prescription No AB 078340 SUN PHARM
IMATINIB MESYLATE IMATINIB MESYLATE EQ 100MG BASE TABLET;ORAL Prescription No AB 204285 TEVA PHARMS USA
IMATINIB MESYLATE IMATINIB MESYLATE EQ 100MG BASE TABLET;ORAL Prescription No AB 210658 ZYDUS PHARMS

TABLET;ORAL; EQ 400MG BASE
TE Code = AB

Drug Name Active Ingredients Strength Dosage Form/Route Marketing Status RLD TE Code Application No. Company
GLEEVEC IMATINIB MESYLATE EQ 400MG BASE TABLET;ORAL Prescription Yes AB 021588 NOVARTIS
IMATINIB MESYLATE IMATINIB MESYLATE EQ 400MG BASE TABLET;ORAL Prescription No AB 079179 APOTEX
IMATINIB MESYLATE IMATINIB MESYLATE EQ 400MG BASE TABLET;ORAL Prescription No AB 208429 CHARTWELL RX
IMATINIB MESYLATE IMATINIB MESYLATE EQ 400MG BASE TABLET;ORAL Prescription No AB 206547 DR REDDYS
IMATINIB MESYLATE IMATINIB MESYLATE EQ 400MG BASE TABLET;ORAL Prescription No AB 212773 EUGIA PHARMA
IMATINIB MESYLATE IMATINIB MESYLATE EQ 400MG BASE TABLET;ORAL Prescription No AB 204644 MYLAN
IMATINIB MESYLATE IMATINIB MESYLATE EQ 400MG BASE TABLET;ORAL Prescription No AB 207818 NATCO PHARMA LTD
IMATINIB MESYLATE IMATINIB MESYLATE EQ 400MG BASE TABLET;ORAL Prescription No AB 212135 QILU PHARM HAINAN
IMATINIB MESYLATE IMATINIB MESYLATE EQ 400MG BASE TABLET;ORAL Prescription No AB 208302 SHILPA
IMATINIB MESYLATE IMATINIB MESYLATE EQ 400MG BASE TABLET;ORAL Prescription No AB 078340 SUN PHARM
IMATINIB MESYLATE IMATINIB MESYLATE EQ 400MG BASE TABLET;ORAL Prescription No AB 204285 TEVA PHARMS USA
IMATINIB MESYLATE IMATINIB MESYLATE EQ 400MG BASE TABLET;ORAL Prescription No AB 210658 ZYDUS PHARMS
Back to Top